E. Gerlach

8.6k total citations
233 papers, 6.6k citations indexed

About

E. Gerlach is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, E. Gerlach has authored 233 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pharmacology, 53 papers in Molecular Medicine and 49 papers in Molecular Biology. Recurrent topics in E. Gerlach's work include Antibiotics Pharmacokinetics and Efficacy (66 papers), Antibiotic Resistance in Bacteria (53 papers) and Antimicrobial Resistance in Staphylococcus (28 papers). E. Gerlach is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (66 papers), Antibiotic Resistance in Bacteria (53 papers) and Antimicrobial Resistance in Staphylococcus (28 papers). E. Gerlach collaborates with scholars based in Germany, United States and Tanzania. E. Gerlach's co-authors include Bernhard F. Becker, B. Deüticke, Ronald N. Jones, J�rgen Schrader, A L Barry, Peter Fuchs, Heinz‐Gerd Zimmer, Gert Baumann, T L Gavan and Francis J. Haddy and has published in prestigious journals such as Circulation Research, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

E. Gerlach

229 papers receiving 5.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E. Gerlach 1.7k 1.3k 1.2k 1.1k 1.0k 233 6.6k
Ken‐ichi Inui 5.3k 3.1× 313 0.3× 2.0k 1.6× 1.2k 1.0× 790 0.8× 502 19.7k
Mario Del Tacca 2.4k 1.4× 623 0.5× 734 0.6× 379 0.3× 544 0.5× 302 7.9k
Erwin Schleicher 4.7k 2.8× 656 0.5× 588 0.5× 945 0.8× 2.9k 2.8× 203 12.0k
Hideyuki Saito 2.5k 1.5× 205 0.2× 1.0k 0.8× 503 0.5× 398 0.4× 273 9.5k
Yusuke Tanigawara 2.1k 1.2× 266 0.2× 1.4k 1.1× 364 0.3× 317 0.3× 177 8.8k
Klaus Resch 4.4k 2.6× 271 0.2× 1.0k 0.8× 321 0.3× 916 0.9× 233 9.5k
Jon G. Mabley 1.9k 1.1× 1.1k 0.9× 241 0.2× 659 0.6× 1.1k 1.1× 85 6.7k
William F. Stenson 3.4k 2.0× 804 0.6× 3.9k 3.2× 494 0.4× 1.4k 1.4× 174 14.4k
Akitoshi Ishizaka 2.0k 1.2× 387 0.3× 417 0.3× 502 0.4× 1.0k 1.0× 200 9.9k
Zhi‐Gang She 3.7k 2.2× 1.2k 1.0× 604 0.5× 585 0.5× 769 0.8× 210 9.8k

Countries citing papers authored by E. Gerlach

Since Specialization
Citations

This map shows the geographic impact of E. Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gerlach more than expected).

Fields of papers citing papers by E. Gerlach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gerlach. The network helps show where E. Gerlach may publish in the future.

Co-authorship network of co-authors of E. Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of E. Gerlach. A scholar is included among the top collaborators of E. Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gerlach. E. Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zahler, Stefan, et al.. (1997). Effects of ACE-inhibition on Redox Status and Expression of P-selectin of Endothelial Cells Subjected to Oxidative Stress. Journal of Molecular and Cellular Cardiology. 29(11). 2953–2960. 14 indexed citations
2.
Doern, Gary V., et al.. (1994). Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testingHaemophilus influenzae on Haemophilus Test Medium. European Journal of Clinical Microbiology & Infectious Diseases. 13(6). 481–489. 1 indexed citations
3.
McLaughlin, J. C., A L Barry, Peter Fuchs, et al.. (1994). In-vitro activity of five β-lactam/β-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 33(2). 223–230. 9 indexed citations
4.
Jones, Ronald N., Gary V. Doern, E. Gerlach, Janet Hindler, & M E Erwin. (1994). Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. Diagnostic Microbiology and Infectious Disease. 18(4). 243–249. 9 indexed citations
5.
Schwartz, Lisa M., et al.. (1993). Adenosine Contributes to Neutrophil-mediated Loss of Myocardial Function in Post-ischemic Guinea-pig Hearts. Journal of Molecular and Cellular Cardiology. 25(8). 927–938. 14 indexed citations
6.
Marshall, Steven A., Ronald N. Jones, Patrick R. Murray, et al.. (1993). In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates. Journal of Antimicrobial Chemotherapy. 32(6). 877–884. 12 indexed citations
7.
Becker, Bernhard F., et al.. (1993). Postischemic dysfunction of the heart induced by small numbers of neutrophils via formation of hypochlorous acid. Basic Research in Cardiology. 88(4). 321–339. 27 indexed citations
8.
Pfaller, Michael A., A L Barry, Peter Fuchs, et al.. (1992). Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam. European Journal of Clinical Microbiology & Infectious Diseases. 11(8). 728–732. 6 indexed citations
9.
Becker, Bernhard F., et al.. (1991). [Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].. PubMed. 69 Suppl 24. 6–9. 2 indexed citations
10.
Becker, Bernhard F., et al.. (1991). Role of Uric Acid as an Endogenous Radical Scavenger and Antioxidant. CHEST Journal. 100(3). 176S–181S. 78 indexed citations
11.
Barry, A L, K E Aldridge, S D Allen, et al.. (1988). In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101. European Journal of Clinical Microbiology & Infectious Diseases. 7(6). 794–798. 3 indexed citations
12.
Newman, Walter H., Bernhard F. Becker, Martin Heier, S. Nees, & E. Gerlach. (1988). Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: studies in isolated guinea pig hearts. Pflügers Archiv - European Journal of Physiology. 413(1). 1–7. 25 indexed citations
13.
Fuchs, Peter, Ronald N. Jones, Arthur L. Barry, et al.. (1986). In vitro evaluation of cefixime (FK027, FR17027, CL284635): Spectrum against recent clinical isolates, comparative antimicrobial activity, β-lactamase stability, and preliminary susceptibility testing criteria. Diagnostic Microbiology and Infectious Disease. 5(2). 151–162. 24 indexed citations
14.
Fuchs, Peter, Ronald N. Jones, A L Barry, et al.. (1986). In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7620 consecutive clinical bacterial isolates. Diagnostic Microbiology and Infectious Disease. 5(4). 345–349. 13 indexed citations
15.
Barry, A L, M B Coyle, Clyde Thornsberry, E. Gerlach, & R W Hawkinson. (1979). Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test. Journal of Clinical Microbiology. 10(6). 885–889. 114 indexed citations
16.
Schrader, Jürgen, S. Nees, & E. Gerlach. (1978). Radioimmunoassay for adenosine in biological samples. Pflügers Archiv - European Journal of Physiology. 378(2). 167–171. 17 indexed citations
17.
Zimmer, Heinz‐Gerd & E. Gerlach. (1978). Stimulation of myocardial adenine nucleotide biosynthesis by pentoses and pentitols. Pflügers Archiv - European Journal of Physiology. 376(3). 223–227. 72 indexed citations
18.
Gerlach, E., et al.. (1975). Alterations of myocardial adenine nucleotide metabolism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7. 121–30. 5 indexed citations
19.
Gerlach, E.. (1973). Erythrocytes, thrombocytes, leukocytes. Recent advances in membrane and metabolic research : 2nd International Symposium, Vienna 1972. Thieme eBooks. 2 indexed citations
20.
Gerlach, E., et al.. (1964). In vitro Inhibition of Migration of Leukocytes by Old Tuberculin (OT) as an Indicator of Active Tuberculosis.. 1(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026